MedBridge Shanghai · International medical facilitation platform recognized under Shanghai Government Document No. 32

ABOUT US

A cross-border facilitation platform — we coordinate care, we do not practise medicine

MedBridge Shanghai is operated by Chengdu Meijiakang Medical Management Co., Ltd. and based in Shanghai. We connect international cancer patients with tertiary oncology centres in China, turning a complex cross-border journey into verifiable steps: case review, specialist consultation, medical visa, on-site support and post-discharge follow-up.

Operating entity

Chengdu Meijiakang Medical Management Co., Ltd.

Unified social credit code

91510107MA6ACY3X4N

Office

2281 Hongqiao Road, Changning District, Shanghai

Role

Cross-border medical consulting & coordination (not a medical institution)

What we do

  • Case feasibility review: we compile imaging, pathology and treatment history and submit them to a partner hospital MDT to judge whether travelling to China is worthwhile and which treatment fits.
  • Expert and hospital matching: based on cancer type, stage and prior treatment, we match the National Cancer Center, provincial cancer hospitals or particle therapy centres.
  • Travel and visa coordination: hospital invitation letters, visa paperwork, airport pickup, accommodation and in-hospital routing.
  • On-site and follow-up support: bilingual coordinators accompany outpatient and inpatient visits, provide English/Russian discharge summaries and arrange remote follow-up.

Credentials and basis

  • International medical facilitation platform recognized under Shanghai Government Document No. 32 (the municipal framework for international medical tourism services).
  • Service process follows GB/T 47801—2026, China's first national standard for medical accompaniment services.
  • A network of 52 tertiary and international hospitals across Shanghai, Beijing and Guangzhou; this site highlights 23 oncology hospitals and 24 specialists from that network.
  • Direct billing and pre-authorization arrangements with 100+ international insurers (applicability depends on the insurer's approval).

Fees and conflicts of interest

We charge only published service fees (two tiers: Essential and All-Inclusive — see the pricing page). Hospital treatment costs are billed by the hospital directly to the patient at official rates; we take no share of hospital revenue and no mark-up on drugs or treatment.

We do not recommend a specific hospital in exchange for a return; our suggestions are based on cancer-type fit, waiting times and prior treatment.

Data and privacy

Medical records are transferred only to the hospital you designate, after your authorization. We process personal data in line with China's PIPL and the GDPR, encrypt transfers and delete records when the retention period ends.

Scope boundary

MedBridge is a licensed cross-border medical consulting and service company, not a medical institution. We do not diagnose, prescribe or operate; every medical decision and procedure is made independently by the partner hospital and its licensed physicians. Information on this site is general in nature and does not constitute medical advice or any guarantee of outcome.

Assess first, then decide

Submit your records and receive a written feasibility opinion from a partner hospital MDT within 3–5 business days, at no charge.

Request a free case review